Skip to main content

Table 3 GSTM1, GSTT1 genotypes distribution among tested patients and healthy controls and susceptibility of PCa

From: Association of CYP1A1, GSTM1 and GSTT1 gene polymorphisms with risk of prostate cancer in Algerian population

  Patients % Controls % OR/CI P value
M+ 43 (42.57) 51(50.49) / /
M 58 (57.42) 50 (49.50) 1.37 [0.76–2.4] 0.26
T+ 63 (62.37) 78 (77.22) / /
T 38 (37.62) 23 (22.77) 2.03 [1.06–3.99] 0.03
M +/T+ 30 (29.70) 41 (40.59) / /
M +/T− 13 (12.87) 10 (9.90) 1.76 [0.62–5.2] 0.33
M−/T+ 33 (32.67) 37 (36.63) 1.21 [0.60–2.5] 0.61
M−/T 25 (24.75) 13 (12.87) 2.6 [1.07–6.5] 0.027
  1. GSTM1 positive (M1 +), GSTM1 null (M1 −), GSTT1 positive (T1 +) and GSTT1 null (T1 −)
  2. OR odds ratios, CI confidence intervals. Wild genotypes were used as a reference (GSTM1 positive, GSTT1 positive)